12.04.07
CMC Biopharmaceuticals A/S has reached an agreement with Lilly to buy the biologics development and manufacturing operation of ICOS Corp., which Lilly bought on in January 2007. CMC, a Copenhagen, Denmark-based bio-CMO, will purchase the biologics facility in Bothell, WA. The new operation, CMC ICOS Biologics Inc., will develop and manufacture therapeutic proteins for early clinical trials.
In a statement, the company said that it is planning "significant investment in the facility to enable production of late-stage clinical trial and commercial biopharmaceuticals." CMC plans to retain the 127 employees currently working at the Bothell facility.
"We're extremely excited about our acquisition of ICOS Biologics. We feel strongly that the skills inherent in the employees that work here are of great value to the biologics industry and will complement the abilities of our expert workforce in Europe," said David Kauffmann, CMC's chairman.
Mads Laustsen, CMC's chief executive officer, remarked, "Our plans to upgrade the facility in order to manufacture commercial product will mean that we can provide additional services to both existing and new clients. Moreover, by establishing a presence in the USA, we've placed CMC in an enhanced position to actively seek opportunities to grow our business."
In a statement, the company said that it is planning "significant investment in the facility to enable production of late-stage clinical trial and commercial biopharmaceuticals." CMC plans to retain the 127 employees currently working at the Bothell facility.
"We're extremely excited about our acquisition of ICOS Biologics. We feel strongly that the skills inherent in the employees that work here are of great value to the biologics industry and will complement the abilities of our expert workforce in Europe," said David Kauffmann, CMC's chairman.
Mads Laustsen, CMC's chief executive officer, remarked, "Our plans to upgrade the facility in order to manufacture commercial product will mean that we can provide additional services to both existing and new clients. Moreover, by establishing a presence in the USA, we've placed CMC in an enhanced position to actively seek opportunities to grow our business."